Sutro Biopharma Inc (STRO)
NASDAQ
Quarter End | 12 2022 | 3 2023 | 6 2023 | 9 2023 | 12 2023 | 3 2024 | 6 2024 | 9 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
総売上 | 8.63M | 12.67M | 10.41M | 16.92M | 113.72M | 13.01M | 25.71M | 8.52M |
営業利益 | -49.22M | -42.24M | -46.18M | -44.01M | 43.15M | -56.59M | -48.69M | -67.92M |
税引前収入 | -34.59M | -49.66M | -38.37M | -47.45M | 46.87M | -58.21M | -48.01M | -48.79M |
純利益 | -34.59M | -50.05M | -38.52M | -49.28M | 31.07M | -58.21M | -48.02M | -48.79M |
優先配当 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
基本的1株当たり利益 (EPS) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EBIT | -49.22M | -42.24M | -46.62M | -52.21M | 39.22M | -63.78M | -55.97M | -67.92M |
EBITDA | -47.69M | -40.62M | -44.45M | -42.28M | 44.88M | -54.83M | -46.9M | -66.12M |
年末 2023年12月31日 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
総売上 | 59.73M | 51.74M | 38.42M | 42.74M | 42.72M | 61.88M | 67.77M | 153.73M |
営業利益 | 1.36M | -19.27M | -37.22M | -55.47M | -71.06M | -98.52M | -128.94M | -89.28M |
税引前収入 | 1.7M | -19.69M | -35.32M | -55.74M | -32.13M | -105.54M | -116.7M | -88.6M |
純利益 | 1.7M | -19.69M | -35.32M | -55.74M | -32.13M | -105.54M | -119.2M | -106.79M |
優先配当 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
基本的1株当たり利益 (EPS) | 3.765 | -42.34 | -1.546 | -2.413 | -0.702 | -2.278 | -2.073 | -1.752 |
EBIT | 1.45M | -19.35M | -35.31M | -55.47M | -71.06M | -98.52M | -128.94M | -101.85M |
EBITDA | 7.03M | -14.28M | -32.68M | -50.69M | -66.76M | -93.68M | -123.25M | -82.46M |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約